Loading…

Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery

Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-(13)C]palmitate and [6,6-(2)H(2)]glucose tra...

Full description

Saved in:
Bibliographic Details
Published in:Diabetologia 2007, Vol.50 (1), p.103-112
Main Authors: BOON, H, BLAAK, E. E, SARIS, W. H. M, KEIZER, H. A, WAGENMAKERS, A. J. M, VAN LOON, L. J. C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43
cites cdi_FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43
container_end_page 112
container_issue 1
container_start_page 103
container_title Diabetologia
container_volume 50
creator BOON, H
BLAAK, E. E
SARIS, W. H. M
KEIZER, H. A
WAGENMAKERS, A. J. M
VAN LOON, L. J. C
description Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-(13)C]palmitate and [6,6-(2)H(2)]glucose tracers were used to assess plasma NEFA and glucose oxidation rates and to estimate the use of muscle- and/or lipoprotein-derived triacylglycerol and muscle glycogen. Subjects were ten male patients who had a long-term (7 +/- 1 years) diagnosis of type 2 diabetes and were overweight, and ten matched healthy, male control subjects. Muscle biopsy samples were collected before and after exercise to assess muscle fibre type-specific intramyocellular lipid and glycogen content. At rest and during exercise, the diabetes patients had greater values than the controls for palmitate rate of appearance (Ra) (rest, 2.46 +/- 0.18 and 1.85 +/- 0.20 respectively; exercise, 3.71 +/- 0.36 and 2.84 +/- 0.20 micromol kg(-1) min(-1)) and rate of disappearance (Rd) (rest, 2.45 +/- 0.18 and 1.83 +/- 0.20; exercise, 3.64 +/- 0.35 and 2.80 +/- 0.20 micromol kg(-1) min(-1) respectively). This was accompanied by significantly higher fat oxidation rates at rest and during recovery in the diabetes patients (rest, 0.11 +/- 0.01 in diabetes patients and 0.09 +/- 0.01 in controls; recovery, 0.13 +/- 0.01 and 0.11 +/- 0.01 g/min respectively), despite significantly greater plasma glucose Ra, Rd and circulating plasma glucose concentrations. Furthermore, exercise significantly lowered plasma glucose concentrations in the diabetes patients, as a result of increased blood glucose disposal. This study demonstrates that substrate source utilisation in long-term-diagnosed type 2 diabetes patients, in whom compensatory hyperinsulinaemia is no longer present, shifts towards an increase in whole-body fat oxidation rate and is accompanied by disturbances in fat and carbohydrate handling.
doi_str_mv 10.1007/s00125-006-0482-2
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_hh_26610</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68378144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhiMEotvCD-CCLCS4QMBfcZxjVcqHVIkDH-JmTZLJ1lXW3nocYI_8c7zsikqcLI-feWf8vlX1RPDXgvP2DXEuZFNzbmqurazlvWoltJLlJu39arV_roU130-qU6IbzrlqtHlYnYhWKCG0XlW_Py895QQZGcUlDciW7GdPkH0MzAc2x7CuM6YNGz2sQyQcWd5tkcl9oceMxLaFxpCJQWYJKb9iEEY2LsmHNcNfmAZP-LdGZRreLgUu4BB_YNo9qh5MMBM-Pp5n1dd3l18uPtRXn95_vDi_qgetmlz3TWckDEK1Xd91YLmZwGiuuUAuOQgQYw8II0oNnW2tntBIM_XFgq41ReOsennQpZ-4XXq3TX4DaeciePfWfzt3Ma3d9bWTxghe6BcHepti2Zey23gacJ4hYFzIGataWxws4LP_wJviYyg_cVIoqxslbYHEARpSJEo4_ZsuuNtH6Q5RuhKl20fpZOl5ehRe-g2Odx3H7Arw_AgADTBPCULx-Y6zWnMlW_UHpsGn2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213845328</pqid></control><display><type>article</type><title>Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery</title><source>Springer Nature</source><creator>BOON, H ; BLAAK, E. E ; SARIS, W. H. M ; KEIZER, H. A ; WAGENMAKERS, A. J. M ; VAN LOON, L. J. C</creator><creatorcontrib>BOON, H ; BLAAK, E. E ; SARIS, W. H. M ; KEIZER, H. A ; WAGENMAKERS, A. J. M ; VAN LOON, L. J. C</creatorcontrib><description>Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-(13)C]palmitate and [6,6-(2)H(2)]glucose tracers were used to assess plasma NEFA and glucose oxidation rates and to estimate the use of muscle- and/or lipoprotein-derived triacylglycerol and muscle glycogen. Subjects were ten male patients who had a long-term (7 +/- 1 years) diagnosis of type 2 diabetes and were overweight, and ten matched healthy, male control subjects. Muscle biopsy samples were collected before and after exercise to assess muscle fibre type-specific intramyocellular lipid and glycogen content. At rest and during exercise, the diabetes patients had greater values than the controls for palmitate rate of appearance (Ra) (rest, 2.46 +/- 0.18 and 1.85 +/- 0.20 respectively; exercise, 3.71 +/- 0.36 and 2.84 +/- 0.20 micromol kg(-1) min(-1)) and rate of disappearance (Rd) (rest, 2.45 +/- 0.18 and 1.83 +/- 0.20; exercise, 3.64 +/- 0.35 and 2.80 +/- 0.20 micromol kg(-1) min(-1) respectively). This was accompanied by significantly higher fat oxidation rates at rest and during recovery in the diabetes patients (rest, 0.11 +/- 0.01 in diabetes patients and 0.09 +/- 0.01 in controls; recovery, 0.13 +/- 0.01 and 0.11 +/- 0.01 g/min respectively), despite significantly greater plasma glucose Ra, Rd and circulating plasma glucose concentrations. Furthermore, exercise significantly lowered plasma glucose concentrations in the diabetes patients, as a result of increased blood glucose disposal. This study demonstrates that substrate source utilisation in long-term-diagnosed type 2 diabetes patients, in whom compensatory hyperinsulinaemia is no longer present, shifts towards an increase in whole-body fat oxidation rate and is accompanied by disturbances in fat and carbohydrate handling.</description><identifier>ISSN: 0012-186X</identifier><identifier>ISSN: 1432-0428</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-006-0482-2</identifier><identifier>PMID: 17131144</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Biological and medical sciences ; Biopsy ; Blood Glucose - metabolism ; Case-Control Studies ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Energy Metabolism - physiology ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Exercise ; Exercise - physiology ; Fatty Acids, Nonesterified - blood ; Glycerol - blood ; Glycogen - metabolism ; Humans ; IMTG ; Insulin - blood ; Lipid Metabolism - physiology ; Male ; Medical sciences ; Middle Aged ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Obesity - metabolism ; Obesity - physiopathology ; Rest - physiology ; Stable isotopes ; Substrate source metabolism ; Type 2 diabetes</subject><ispartof>Diabetologia, 2007, Vol.50 (1), p.103-112</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43</citedby><cites>FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18440327$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17131144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-26610$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>BOON, H</creatorcontrib><creatorcontrib>BLAAK, E. E</creatorcontrib><creatorcontrib>SARIS, W. H. M</creatorcontrib><creatorcontrib>KEIZER, H. A</creatorcontrib><creatorcontrib>WAGENMAKERS, A. J. M</creatorcontrib><creatorcontrib>VAN LOON, L. J. C</creatorcontrib><title>Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><description>Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-(13)C]palmitate and [6,6-(2)H(2)]glucose tracers were used to assess plasma NEFA and glucose oxidation rates and to estimate the use of muscle- and/or lipoprotein-derived triacylglycerol and muscle glycogen. Subjects were ten male patients who had a long-term (7 +/- 1 years) diagnosis of type 2 diabetes and were overweight, and ten matched healthy, male control subjects. Muscle biopsy samples were collected before and after exercise to assess muscle fibre type-specific intramyocellular lipid and glycogen content. At rest and during exercise, the diabetes patients had greater values than the controls for palmitate rate of appearance (Ra) (rest, 2.46 +/- 0.18 and 1.85 +/- 0.20 respectively; exercise, 3.71 +/- 0.36 and 2.84 +/- 0.20 micromol kg(-1) min(-1)) and rate of disappearance (Rd) (rest, 2.45 +/- 0.18 and 1.83 +/- 0.20; exercise, 3.64 +/- 0.35 and 2.80 +/- 0.20 micromol kg(-1) min(-1) respectively). This was accompanied by significantly higher fat oxidation rates at rest and during recovery in the diabetes patients (rest, 0.11 +/- 0.01 in diabetes patients and 0.09 +/- 0.01 in controls; recovery, 0.13 +/- 0.01 and 0.11 +/- 0.01 g/min respectively), despite significantly greater plasma glucose Ra, Rd and circulating plasma glucose concentrations. Furthermore, exercise significantly lowered plasma glucose concentrations in the diabetes patients, as a result of increased blood glucose disposal. This study demonstrates that substrate source utilisation in long-term-diagnosed type 2 diabetes patients, in whom compensatory hyperinsulinaemia is no longer present, shifts towards an increase in whole-body fat oxidation rate and is accompanied by disturbances in fat and carbohydrate handling.</description><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Blood Glucose - metabolism</subject><subject>Case-Control Studies</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Energy Metabolism - physiology</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Exercise</subject><subject>Exercise - physiology</subject><subject>Fatty Acids, Nonesterified - blood</subject><subject>Glycerol - blood</subject><subject>Glycogen - metabolism</subject><subject>Humans</subject><subject>IMTG</subject><subject>Insulin - blood</subject><subject>Lipid Metabolism - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Obesity - metabolism</subject><subject>Obesity - physiopathology</subject><subject>Rest - physiology</subject><subject>Stable isotopes</subject><subject>Substrate source metabolism</subject><subject>Type 2 diabetes</subject><issn>0012-186X</issn><issn>1432-0428</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhiMEotvCD-CCLCS4QMBfcZxjVcqHVIkDH-JmTZLJ1lXW3nocYI_8c7zsikqcLI-feWf8vlX1RPDXgvP2DXEuZFNzbmqurazlvWoltJLlJu39arV_roU130-qU6IbzrlqtHlYnYhWKCG0XlW_Py895QQZGcUlDciW7GdPkH0MzAc2x7CuM6YNGz2sQyQcWd5tkcl9oceMxLaFxpCJQWYJKb9iEEY2LsmHNcNfmAZP-LdGZRreLgUu4BB_YNo9qh5MMBM-Pp5n1dd3l18uPtRXn95_vDi_qgetmlz3TWckDEK1Xd91YLmZwGiuuUAuOQgQYw8II0oNnW2tntBIM_XFgq41ReOsennQpZ-4XXq3TX4DaeciePfWfzt3Ma3d9bWTxghe6BcHepti2Zey23gacJ4hYFzIGataWxws4LP_wJviYyg_cVIoqxslbYHEARpSJEo4_ZsuuNtH6Q5RuhKl20fpZOl5ehRe-g2Odx3H7Arw_AgADTBPCULx-Y6zWnMlW_UHpsGn2A</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>BOON, H</creator><creator>BLAAK, E. E</creator><creator>SARIS, W. H. M</creator><creator>KEIZER, H. A</creator><creator>WAGENMAKERS, A. J. M</creator><creator>VAN LOON, L. J. C</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8Z</scope></search><sort><creationdate>2007</creationdate><title>Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery</title><author>BOON, H ; BLAAK, E. E ; SARIS, W. H. M ; KEIZER, H. A ; WAGENMAKERS, A. J. M ; VAN LOON, L. J. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Blood Glucose - metabolism</topic><topic>Case-Control Studies</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Energy Metabolism - physiology</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Exercise</topic><topic>Exercise - physiology</topic><topic>Fatty Acids, Nonesterified - blood</topic><topic>Glycerol - blood</topic><topic>Glycogen - metabolism</topic><topic>Humans</topic><topic>IMTG</topic><topic>Insulin - blood</topic><topic>Lipid Metabolism - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Obesity - metabolism</topic><topic>Obesity - physiopathology</topic><topic>Rest - physiology</topic><topic>Stable isotopes</topic><topic>Substrate source metabolism</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOON, H</creatorcontrib><creatorcontrib>BLAAK, E. E</creatorcontrib><creatorcontrib>SARIS, W. H. M</creatorcontrib><creatorcontrib>KEIZER, H. A</creatorcontrib><creatorcontrib>WAGENMAKERS, A. J. M</creatorcontrib><creatorcontrib>VAN LOON, L. J. C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Högskolan i Halmstad</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOON, H</au><au>BLAAK, E. E</au><au>SARIS, W. H. M</au><au>KEIZER, H. A</au><au>WAGENMAKERS, A. J. M</au><au>VAN LOON, L. J. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery</atitle><jtitle>Diabetologia</jtitle><addtitle>Diabetologia</addtitle><date>2007</date><risdate>2007</risdate><volume>50</volume><issue>1</issue><spage>103</spage><epage>112</epage><pages>103-112</pages><issn>0012-186X</issn><issn>1432-0428</issn><eissn>1432-0428</eissn><abstract>Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-(13)C]palmitate and [6,6-(2)H(2)]glucose tracers were used to assess plasma NEFA and glucose oxidation rates and to estimate the use of muscle- and/or lipoprotein-derived triacylglycerol and muscle glycogen. Subjects were ten male patients who had a long-term (7 +/- 1 years) diagnosis of type 2 diabetes and were overweight, and ten matched healthy, male control subjects. Muscle biopsy samples were collected before and after exercise to assess muscle fibre type-specific intramyocellular lipid and glycogen content. At rest and during exercise, the diabetes patients had greater values than the controls for palmitate rate of appearance (Ra) (rest, 2.46 +/- 0.18 and 1.85 +/- 0.20 respectively; exercise, 3.71 +/- 0.36 and 2.84 +/- 0.20 micromol kg(-1) min(-1)) and rate of disappearance (Rd) (rest, 2.45 +/- 0.18 and 1.83 +/- 0.20; exercise, 3.64 +/- 0.35 and 2.80 +/- 0.20 micromol kg(-1) min(-1) respectively). This was accompanied by significantly higher fat oxidation rates at rest and during recovery in the diabetes patients (rest, 0.11 +/- 0.01 in diabetes patients and 0.09 +/- 0.01 in controls; recovery, 0.13 +/- 0.01 and 0.11 +/- 0.01 g/min respectively), despite significantly greater plasma glucose Ra, Rd and circulating plasma glucose concentrations. Furthermore, exercise significantly lowered plasma glucose concentrations in the diabetes patients, as a result of increased blood glucose disposal. This study demonstrates that substrate source utilisation in long-term-diagnosed type 2 diabetes patients, in whom compensatory hyperinsulinaemia is no longer present, shifts towards an increase in whole-body fat oxidation rate and is accompanied by disturbances in fat and carbohydrate handling.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>17131144</pmid><doi>10.1007/s00125-006-0482-2</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2007, Vol.50 (1), p.103-112
issn 0012-186X
1432-0428
1432-0428
language eng
recordid cdi_swepub_primary_oai_DiVA_org_hh_26610
source Springer Nature
subjects Biological and medical sciences
Biopsy
Blood Glucose - metabolism
Case-Control Studies
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - physiopathology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Energy Metabolism - physiology
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Exercise
Exercise - physiology
Fatty Acids, Nonesterified - blood
Glycerol - blood
Glycogen - metabolism
Humans
IMTG
Insulin - blood
Lipid Metabolism - physiology
Male
Medical sciences
Middle Aged
Muscle, Skeletal - metabolism
Muscle, Skeletal - pathology
Obesity - metabolism
Obesity - physiopathology
Rest - physiology
Stable isotopes
Substrate source metabolism
Type 2 diabetes
title Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A13%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substrate%20source%20utilisation%20in%20long-term%20diagnosed%20type%202%20diabetes%20patients%20at%20rest,%20and%20during%20exercise%20and%20subsequent%20recovery&rft.jtitle=Diabetologia&rft.au=BOON,%20H&rft.date=2007&rft.volume=50&rft.issue=1&rft.spage=103&rft.epage=112&rft.pages=103-112&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-006-0482-2&rft_dat=%3Cproquest_swepu%3E68378144%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-b5962ac1379b99a806fa640401e020a1a1dbaeade24a98784fe626fb012976c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=213845328&rft_id=info:pmid/17131144&rfr_iscdi=true